Lawrence R. Hoffman

Lawrence R.
Hoffman currently works at Pennsylvania Institute of Certified Public Accountants, as Member, Pennsylvania State Bar Association, as Member, and Danforth Advisors LLC, as Member from 2021.
Mr. Hoffman also formerly worked at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., as Chief Financial Officer & Vice President from 2000 to 2003, The Liposome Co., Inc., as Chief Financial Officer & Vice President from 1998 to 2000, LANXESS Sybron Chemicals, Inc., as Acting Chief Financial Officer & Secretary, Covalent Group, Inc., as Chief Financial Officer & Executive Vice President, SCYNEXIS, Inc., as Chief Financial Officer from 2021 to 2022, Aptiv Solutions, Inc. (Massachusetts), as Chief Financial & Accounting Officer in 2010, Encorium Group, Inc., as CFO, Secretary, EVP & General Counsel from 2004 to 2008, Sermonix Pharmaceuticals LLC, as Chief Financial Officer from 2018 to 2021, and Tenax Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024.
Mr. Hoffman received his undergraduate degree from LaSalle University, graduate degree from Temple University (Pennsylvania), and graduate degree from Villanova University.